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TECHNICAL NOTE
Use of computerized tomography to diagnose complications
of percutaneous renal biopsy
ROBERT ROSENBAUM, PHILLIP E. HOFFSTEN, ROBERT J. STANLEY, and SAULO KLAHR
Renal Division, Department of Internal Medicine, and the Edward Mallinckrodt Institute of Radiology, Washington
University School of Medicine, St. Louis, Missouri
Complications following percutaneous renal bi-
opsy have been infrequent with a 0.7% reported
incidence [1—3]. Recently, an analysis of 1,000 con-
secutive renal biopsies yielded an overall complica-
tion rate of 9.4% [41. Complications considered in-
cluded gross hematuria, perirenal hematoma,
oliguric obstruction, or hypertension. Specifically,
the incidence of perirenal hematomas in this report
was only 1.4%.
We have noted a small but consistent decrease in
hematocrit following percutaneous renal biopsy, an
observation also recently reported by Bolten [5].
Review of 342 biopsies revealed that the decrease in
hematocrit was 4% or less in 80% of these cases,
with only one complication in this group. Considera-
tion of the cause for the hematocrit drop in these
uncomplicated cases led to the hypothesis that the
incidence of subclinical penrenal hematomas might
be quite high. To assess this possibility, computed
tomography (CT) was employed as a sensitive, non-
invasive technique for demonstrating the presence of
subclinical perirenal hematomas.
Retrospectively, 342 percutaneous renal biopsy
cases were analyzed for hematocrit changes and re-
corded complications. Prospectively, 20 consecutive
patients undergoing percutaneous renal biopsy, from
May through October, 1977, with fluoroscopic tech-
niques [61 underwent a CT scan of the abdomen one
day following percutaneous renal biopsy. Fourteen
of these patients had a repeat scan one to three
months after biopsy. All prospective biopsies were
performed utilizing the Franklin modification of the
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Vim-Silverman needle under fluoroscopic control,
with radiographic contrast agent to visualize the col-
lecting system and nephrogram. Two specimens of
tissue were obtained from each patient. Intraopera-
tively, each patient was required to hold a full inspi-
ration whenever the biopsy needle was positioned or
manipulated, usually for about 15 to 20 sec, to avoid
movement of the kidney. Postoperatively, each pa-
tient remained horizontal, usually for at least 24 hr
following biopsy. If gross hematuria or if a hemato-
crit decrease greater than 4% occurred, complete
bed rest was maintained for 48 to 72 hr or until gross
hematuria disappeared or hematocrit stabilized for
48 hr. No local application of pressure was utilized.
Regular diet and fluids were begun after the biopsy.
Twenty-four hours prior to biopsy, all patients were
evaluated and were found to have a normal coagula-
tion system. The examinations performed included
platelet count, prothrombin time, partial thrombo-
plastin time, clotting time, bleeding time, and clot
retraction. Hematocrits were obtained on the morn-
ing of biopsy and at 8, 24, 48, and 72 hr following
biopsy. A negative urine culture was documented on
each patient prior to biopsy. Twenty consecutive
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patients underwent percutaneous renal biopsy for
diagnosis of newly found nephrotic syndrome, or to
determine renal involvement in systemic lupus ery-
thematosus. The 20 patients ranged in age from 24 to
72 yr, with a mean age of 42 yr. Fifteen of the
patients were normotensive. Five patients required
antihypertensive therapy prior to and after biopsy.
Blood pressure was maintained at or below 140/80
mm Hg in the supine position. Creatinine clearance
ranged from 120 to 25 cc/mm. Patients were not
allowed to have salicylates for 72 hr preceding bi-
opsy, nor were they given pain medication after
biopsy. Other drugs known to affect clotting parame-
ters were not taken by any patient prior to biopsy.
Kidney size was determined by prior i.v. pyelogra-
phy and was deemed normal for body size and age in
all patients.
The distribution of decreases in hematocrit in the
retrospective biopsy group (342 patients) is shown in
Table 1. Only one clinically significant complication
(a subeapsular hematoma) was seen in the group of
patients with a decrease in hematocrit of 4% or less
(Table 2). In the 20% of patients with a decrease in
hematocrit greater than 4%, there were 16 clinically
significant complications. It is noteworthy that he-
matocrit decreases of 4 to 13% were observed in the
absence of gross hematuria, changes in blood pres-
sure, fever, or local pain.
Of the 20 patients studied prospectively, clinically
significant complications developed in only one. This
patient had a 10% decrease in hematocrit and local
flank pain at the biopsy site, without gross hematu-
na, or hypotension. CT scan demonstrated a pen-
renal hematoma. The extent of the hematoma is
shown in Figure 1, where a large posterior perirenal
hematoma may be seen; this hematoma was not
detectable on repeat CT scan three months later.
Angiography one day postbiopsy revealed the right
kidney to be markedly displaced in an anterior and
superior direction with the upper pole directed medi-
ally. No therapy other than bed rest was necessary
for this patient. Another patient with gross hematuria
Table 1. Distribution of decreases in hematocrit following
percutaneous renal biopsy in 342 cases
HematocriI decrease, %
0% 1—4% 5—9% 10—13%
No. of patients 111 165 59 7
Percent of total (32%) (48.2%) (17.2%) (2.7%)
Incidence of clinically
recognized
complications 0 1 11 5
Table 2. Complications following percutaneous renal biopsy in
342 patients studied retrospectively
Patient no. Hct decrease, % Complication
1 4 Subcapsular hematoma
2 5 Gross hematuria-hypotension, 4
U BW
3 5 Gross hematuria, 3 U BR
4 5 Delayed bleeding with clots in
bladder
5 6 Hypotension-flank pain, anuria,
deathb
6 6 Hypotension-gross hematuria. 2
U BR
7 6 Perirenal hematoma, 3 U BR
8 6 Perirenal hematoma, hypertension
nephrectomy
9 7 Hypotension, 3 U BR
10 7 Recurrent gross hematuria. hypo-
tension, heminephrectomy.
death, multiple BR
11 9 Hypotension, 2 U BR
12 9 Local bleeding, clots in bladder
13 10 Gross hematuria, bladder clots, 6
U BR
14 10 Gross hematuna, 2 U BR
15 12 Hypotension
16 12 Abdominal pain
17 13 Hypotension, 3 U BR
BR, blood replacement in units of either packed cells or whole
blood.
5Biopsied in 1961 for acute renal failure, 7 U of BR.
Prebiopsy active urinary tract infection, death from infected
perirenal hematoma and sepsis.
had contrast medium from the previous day's infu-
sion in the hematoma, suggesting a leak from the
urinary collecting system into the perirenal hema-
toma (Fig. 2a). Infusion of a second bolus of contrast
medium demonstrated a communication between the
hematoma and the renal collecting system (Fig. 2b).
This patient maintained a stable blood pressure,
pulse, and hematocrit with cessation of gross hema-
tuna two days following renal biopsy. No specific
therapy other than bed rest was required. Seventeen
patients had less than a 4% decrease in their hemato-
crit (Table 3), yet 14 had a demonstrable penirenal
hematoma visualized by CT scan (Fig. 3). Fourteen
of 20 patients had repeat CT scan examinations one
to three months following biopsy. All previously
noted perirenal hematomas had resolved.
Computed tomography of the body, introduced in
early 1975, demonstrates normal and pathologic
anatomy in a unique, cross-sectional format, un-
matched in clarity by other methods [7, 81. It is a
very sensitive technique for detecting intraabdominal
hemorrhage and, specifically, perirenal hematomas
119, 101. Although not fully understood, acute hema-
tomas in the abdomen have a higher attenuation
value than flowing blood, a phenomenon well-recog-
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Fig 1. a) CT scan at the level of the midzone of the right kidney demonstrating a large
perinephric hematoma (white arrows) surrounding all but the medial surface of the right
kidney. Note that the density of the hematoma is slightly greater than the adjacent renal
parenchyma. Compare also to the density of the left kidney. b) Follow up CT scan, 3 months
after renal biopsy, demonstrating complete resolution of the right-sided perinephric
hematoma.
nized in CT brain-scanning [11, 121. A perinephric
hematoma will commonly appear denser than the
adjacent renal parenchyma.
The incidence of penrenal hematomas has previ-
ously been reported to be 14 cases in 1,000 biopsies
114]. It might be expected, however, that puncture of
an organ receiving approximately one-fifth of the
cardiac output per minute at rest at systemic blood
pressure would lead to the development of significant
hemorrhage. Our data reveal an 85% incidence of
perirenal hematoma formation in 20 consecutive pa-
tients following percutaneous renal biopsy as deter-
mined by CT scanning. Fourteen of these docu-
mented perirenal hematomas occurred with little or
no change in hematocrit, blood pressure, or pulse
rate. Only one patient had a clinically evident corn-
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Fig. 2. a) CT scan of the right kidney, showing a subcapsular collection of contrast medium
from the previous days injection. Also present is a small perinephric hematoma. b) Detail view
of the right kidney after injection of contrast medium the day after biopsy, showing intensifica-
tion of the unusual concentration of contrast medium in the cortical pa renchyma. In addition,
there may be a communication (white arrows) between the renal collecting system and the
cortical collection of contrast material (black arrows).
Table 3. Correlation of perirenal hematoma as demonstrated by
computerized tomography with decreases in hematocrit following
percutaneous renal biopsy
Hematocrit decrease
0% 1—4% 5—9% >10
No. of patients 7 10 2 1
Perirenal hematoma proven
byCTscan 4 10 2 1
plication, evidenced by flank pain and a 10% de-
crease in hematocrit.
All observed hematomas, as demonstrated by fol-
low-up CT scan, resolved at one to three months
without residual calcification. It is noteworthy that
the renal capsule did not limit accumulation of a
hematoma within the subcapsular space, thus ex-
plaining why compression of the renal parenchyma
leading to hypertension occurs rarely [13].
We feel that perirenal hematomas following percu-
taneous renal biopsy occur more frequently than has
been previously recognized, as judged by CT scan.
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Fig. 3. CT scans at the level of the kidneys in four separate patients demonstrating the varying size and appearance of the postrenal biopsy
perinephric hematomas. a) A large, dense perinephnc hematoma (white arrows) displaces the right kidney anteriorly and appears to dissect
out into adjacent fascial spaces. b) Similar anterior displacement of the right kidney is produced by a moderate-sized, postbiopsy pennephric
hematoma (white arrows). In this case the hematoma does not have the same high density as the hematoma seen in Figure a. c and d) These
scans illustrate small pennephnc hematomas (arrows) which layer out along the posterior perirenal fascia and are generally confined to this
space by the fascial plane.
Those perirenal hematomas associated with less than
a 4% decrease in hernatocrit are not likely to result in
significant clinical problems, while hematomas asso-
ciated with greater than a 4% decrease in hematocrit
are likely to cause complications requiring major
physician intervention. Because infection of a pen-
renal hematoma can be catastrophic [14], we feel
that the presence of an active, untreated urinary tract
infection represents a contraindication to the perfor-
mance of percutaneous renal biopsy, especially in
view of the potential communication of the collecting
system and the perirenal hematoma as demonstrated
in Figure 2b.
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